{"disease":{"id":"gastric-stomach-cancer","name":"gastric stomach cancer"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06943807","title":"Prospective Gastric Cancer Screening With Fecal Multi-target DNA Analysis","phase":"","overall_status":"RECRUITING","enrollment_count":15000,"lead_sponsor_name":"Fudan University","has_results":false},{"nct_id":"NCT06943768","title":"Fecal DNA Methylation and Helicobacter Pylori Gastric Cancer Susceptibility Genes Test","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":9654,"lead_sponsor_name":"Fudan University","has_results":false},{"nct_id":"NCT07213115","title":"Epidemiology and Treatment of Gastric Cancer","phase":"","overall_status":"COMPLETED","enrollment_count":8582,"lead_sponsor_name":"Medizinische Hochschule Brandenburg Theodor Fontane","has_results":false},{"nct_id":"NCT06943794","title":"Eradication of Helicobacter Pylori Subtypes at High Gastric Cancer Risk: a Cluster-randomized Controlled Trial","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":4824,"lead_sponsor_name":"Fudan University","has_results":false},{"nct_id":"NCT06896370","title":"An Observational Study for Gastric Cancer in Carriers of High Risk Helicobacter Pylori","phase":"","overall_status":"RECRUITING","enrollment_count":3000,"lead_sponsor_name":"Fudan University","has_results":false},{"nct_id":"NCT07312500","title":"Fecal DNA Methylation and Helicobacter Pylori SNPs Tests for Gastric Cancer","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":3000,"lead_sponsor_name":"Fudan University","has_results":false},{"nct_id":"NCT05431621","title":"Establishment of Molecular Classification Models for Early Diagnosis of Digestive System Cancers","phase":"","overall_status":"COMPLETED","enrollment_count":2430,"lead_sponsor_name":"Shanghai Zhongshan Hospital","has_results":false},{"nct_id":"NCT07481110","title":"Study of the Epidemiological, Clinical, Diagnostic, and Therapeutic Characteristics of Gastric Cancers in Algeria","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Société Algérienne de Formation et Recherche en Oncologie","has_results":false},{"nct_id":"NCT03030404","title":"Hereditary Gastric Cancer Syndromes: An Integrated Genomic and Clinicopathologic Study of the Predisposition to Gastric Cancer","phase":"","overall_status":"COMPLETED","enrollment_count":733,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT06277908","title":"Postoperative Morbidity and Mortality After Gastric Cancer Surgery","phase":"","overall_status":"UNKNOWN","enrollment_count":700,"lead_sponsor_name":"P. Herzen Moscow Oncology Research Institute","has_results":false},{"nct_id":"NCT06763068","title":"Skeletal Muscle Mass Used to Assess Frailty in Older Gastric Cancer Patients","phase":"","overall_status":"COMPLETED","enrollment_count":575,"lead_sponsor_name":"Nanjing Medical University","has_results":false},{"nct_id":"NCT06858644","title":"Development of a Predictive Model for Gastric Cancer Peritoneal Metastasis and Cachexia Using BUB1 and Radiopathomics Data With Deep Learning","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":500,"lead_sponsor_name":"Qun Zhao","has_results":false},{"nct_id":"NCT04907643","title":"Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes","phase":"NA","overall_status":"RECRUITING","enrollment_count":360,"lead_sponsor_name":"Cedars-Sinai Medical Center","has_results":false},{"nct_id":"NCT06316882","title":"Gastric Cancer Endoscopic Screening in an Intermediate-risk Country - ROGCAS, a Dual-centre Pilot Program","phase":"","overall_status":"COMPLETED","enrollment_count":349,"lead_sponsor_name":"Unidade Local De Saúde Do Norte Alentejano","has_results":false},{"nct_id":"NCT07371663","title":"An Phase Ib/II Clinical Trial of TCC1727 Combination Therapy in Advanced Solid Tumors","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":266,"lead_sponsor_name":"Beijing Tide Pharmaceutical Co., Ltd","has_results":false},{"nct_id":"NCT06028737","title":"Total Neoadjuvant FLOT Chemotherapy in Locally Advanced Gastric and Gastroesophageal Junction Cancer","phase":"PHASE2, PHASE3","overall_status":"RECRUITING","enrollment_count":150,"lead_sponsor_name":"Ukrainian Society of Clinical Oncology","has_results":false},{"nct_id":"NCT06979895","title":"Investigating Multigene Methylation Dynamics in Treatment Response Surveillance for Gastric Cancer","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":150,"lead_sponsor_name":"Xijing Hospital","has_results":false},{"nct_id":"NCT06997302","title":"A Study on the Impact of Intelligent Nutrition Management on Clinical Outcomes in Chemotherapy Patients With Gastrointestinal Malignancies","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":150,"lead_sponsor_name":"Tianjin Medical University Cancer Institute and Hospital","has_results":false},{"nct_id":"NCT06748508","title":"Comparing the Efficacy of Sintilimab Plus Nab-POF Regimen, Sintilimab Plus XELOX Chemotherapy, and Lenvatinib, Sintilimab Plus XELOX Chemotherapy in the Treatment of HER2-negative, Metastatic Gastric Cancer","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":141,"lead_sponsor_name":"Fudan University","has_results":false},{"nct_id":"NCT04044859","title":"ADP-A2M4CD8 as Monotherapy or in Combination With Either Nivolumab or Pembrolizumab in HLA-A2+ Subjects With MAGE-A4 Positive Tumors (SURPASS)","phase":"PHASE1","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":120,"lead_sponsor_name":"USWM CT, LLC","has_results":false},{"nct_id":"NCT07356466","title":"Clinical Efficacy of Pucotenlimab Combined With Lenvatinib and SOX Versus SOX Alone in Patients With HER2-Negative Advanced Gastric or Gastroesophageal Junction Adenocarcinoma","phase":"EARLY_PHASE1","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":100,"lead_sponsor_name":"Fujian Medical University","has_results":false},{"nct_id":"NCT06741124","title":"Comparison of Channel Esophagogastrostomy and Double Tract Reconstruction After Laparoscopic-assist Proximal Gastrectomy: A Propensity Score-Matched Analysis","phase":"","overall_status":"COMPLETED","enrollment_count":99,"lead_sponsor_name":"Northern Jiangsu People's Hospital","has_results":false},{"nct_id":"NCT01257711","title":"A Study Comparing Billroth II With Roux-en-Y Reconstruction for Gastric Cancer","phase":"NA","overall_status":"COMPLETED","enrollment_count":96,"lead_sponsor_name":"National Healthcare Group, Singapore","has_results":false},{"nct_id":"NCT07212933","title":"The Safety and Clinical Efficacy of RAK Cell Therapy in Late-stage Gastric Cancer: A Randomized Controlled Trial","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":90,"lead_sponsor_name":"Chinese PLA General Hospital","has_results":false},{"nct_id":"NCT03129139","title":"A Phase 1, Multi-Center, Open-Label, Dose-Escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of Minnelide™ Capsules Given Alone or in Combination With Protein-Bound Paclitaxel in Patients With Advanced Solid Tumors","phase":"PHASE1","overall_status":"UNKNOWN","enrollment_count":66,"lead_sponsor_name":"Minneamrita Therapeutics LLC","has_results":false},{"nct_id":"NCT06742411","title":"XELOX Combined With Sintilimab and HBO for Advanced or Metastatic GC/GEJC","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":57,"lead_sponsor_name":"West China Hospital","has_results":false},{"nct_id":"NCT06732856","title":"A Phase Ib/II Trial of Neoadjuvant Zolbetuximab Plus Docetaxel, Oxaliplatin and S-1 Chemotherapy in Patients With Locally Advanced Gastric Cancer","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":57,"lead_sponsor_name":"Asan Medical Center","has_results":false},{"nct_id":"NCT03515356","title":"Exercise to Reduce Chemotherapy-Induced Peripheral Neuropathy","phase":"NA","overall_status":"COMPLETED","enrollment_count":54,"lead_sponsor_name":"University of Michigan Rogel Cancer Center","has_results":false},{"nct_id":"NCT07387237","title":"Multigene Germline Panel Testing in Gastric Cancer Patients in Portugal","phase":"","overall_status":"COMPLETED","enrollment_count":51,"lead_sponsor_name":"Unidade Local De Saúde Do Norte Alentejano","has_results":false},{"nct_id":"NCT04660929","title":"CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors","phase":"PHASE1","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":48,"lead_sponsor_name":"Carisma Therapeutics Inc","has_results":false},{"nct_id":"NCT02576548","title":"A Phase 1/2 Study of MEDI4276 in Adults Subjects With Select HER2-expressing Advanced Solid Tumors.","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":47,"lead_sponsor_name":"MedImmune LLC","has_results":false},{"nct_id":"NCT07334431","title":"Fruquintinib Combined With Trastuzumab and XELOX as First-line Treatment in Patients With HER2-positive Advanced Gastric Cancer","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":45,"lead_sponsor_name":"Henan Cancer Hospital","has_results":false},{"nct_id":"NCT06871527","title":"Fruquintinib Combined With PD-1 Inhibitor and FOLFOX as First-Line Treatment For Advanced Gastric Cancer","phase":"PHASE1, PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":44,"lead_sponsor_name":"Sixth Affiliated Hospital, Sun Yat-sen University","has_results":false},{"nct_id":"NCT05187182","title":"CA-4948 in Combination With FOLFOX/PD-1 Inhibitor +/- Trastuzumab for Untreated Unresectable Gastric and Esophageal Cancer","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":42,"lead_sponsor_name":"Washington University School of Medicine","has_results":false},{"nct_id":"NCT03652077","title":"A Safety and Tolerability Study of INCAGN02390 in Select Advanced Malignancies","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":40,"lead_sponsor_name":"Incyte Corporation","has_results":false},{"nct_id":"NCT06487221","title":"Avutometinib and Defactinib in Diffuse Gastric Cancer","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":27,"lead_sponsor_name":"Ryan H. Moy, MD, PhD","has_results":false},{"nct_id":"NCT07447050","title":"Riluzole For Preventing Cognitive Dysfunction in Ca Pts Receiving Chemo (REFOCUS): Pilot Trial","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":24,"lead_sponsor_name":"University of California, Irvine","has_results":false},{"nct_id":"NCT03538028","title":"A Safety and Tolerability Study of INCAGN02385 in Select Advanced Malignancies","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":22,"lead_sponsor_name":"Incyte Biosciences International Sàrl","has_results":false},{"nct_id":"NCT05311176","title":"A Study of IMU-131 (HER-Vaxx) in Combination With Chemotherapy or Pembrolizumab in Patients With Metastatic HER2/Neu Over-Expressing Gastric Cancer (nextHERIZON)","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":7,"lead_sponsor_name":"Imugene Limited","has_results":true},{"nct_id":"NCT03704077","title":"An Investigational Immuno-therapy Study of Relatlimab Plus Nivolumab Compared to Various Standard-of-Care Therapies in Previously Treated Participants With Recurrent, Advanced or Metastatic Gastric Cancer or Gastroesophageal Junction Adenocarcinoma","phase":"PHASE2","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Bristol-Myers Squibb","has_results":false}],"total":40},"guidelines":[],"source":"Drug Landscape verified database"}